- Report
- May 2024
- 185 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- February 2024
- 150 Pages
Global
From €4051EUR$4,250USD£3,475GBP
- Report
- March 2024
- 194 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- January 2024
- 348 Pages
Global
From €5248EUR$5,699USD£4,350GBP
- Report
- October 2023
- 150 Pages
Global
From €4623EUR$4,850USD£3,965GBP
- Report
- November 2022
- 148 Pages
Global
From €5242EUR$5,500USD£4,497GBP
- Report
- March 2024
- 150 Pages
From €4947EUR$5,190USD£4,243GBP
- Report
- April 2023
- 117 Pages
Global
From €4527EUR$4,750USD£3,884GBP
- Report
- August 2020
- 114 Pages
Global
From €4051EUR$4,250USD£3,475GBP
- Report
- August 2021
- 120 Pages
Global
From €4241EUR$4,450USD£3,638GBP
- Report
- May 2024
- 100 Pages
From €3617EUR$3,795USD£3,103GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
- Report
- April 2024
- 80 Pages
From €2473EUR$2,595USD£2,122GBP
The Pulmonary Drug market is a subset of the larger Respiratory Drug market, which includes treatments for a variety of respiratory diseases and conditions. Pulmonary Drugs are used to treat diseases and conditions of the lungs, such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pulmonary hypertension. These drugs are typically inhaled, and can include bronchodilators, corticosteroids, and antibiotics. In addition, Pulmonary Drugs can also be used to treat other respiratory conditions, such as sleep apnea and snoring.
The Pulmonary Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and AstraZeneca. Other companies, such as Boehringer Ingelheim, Cipla, and Sun Pharmaceuticals, also offer Pulmonary Drugs. Show Less Read more